Gibco HT Supplement is a liquid mixture of sodium hypoxanthine (10 mM) and thymidine (1.6 mM). HT-supplemented medium is suitable深入閱讀
Have Questions?
產品號碼
Quantity
11067030
50 mL
產品號碼 11067030
價格 (TWD)
1,830.00
온라인 행사
Ends: 31-Dec-2025
2,440.00
您節省 610.00 (25%)
Each
新增至購物車
Quantity:
50 mL
價格 (TWD)
1,830.00
온라인 행사
Ends: 31-Dec-2025
2,440.00
您節省 610.00 (25%)
Each
新增至購物車
Gibco HT Supplement is a liquid mixture of sodium hypoxanthine (10 mM) and thymidine (1.6 mM). HT-supplemented medium is suitable for post-selection rescue to overcome the effects of residual intracellular aminopterin. Once the de novo biosynthesis pathway for nucleosides has been reestablished, HT supplementation can be discontinued.
cGMP Manufacturing and Quality System For supply chain continuity, we manufacture Gibco HT Supplement (100X) at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements and are certified to ISO 13485 and are certified to the ISO 13485 standard.
For Research Use Only. Not for use in diagnostic procedures.
規格
Concentration100 X
Quantity50 mL
Shelf Life18 Months
Shipping ConditionRoom Temperature
FormLiquid
Product TypeHT Supplement
SterilitySterile-filtered
Unit SizeEach
內容物與存放
Storage conditions: 2°C to 8°C Shipping conditions: Room temperature Shelf life: 18 months from date of manufacture
引用資料與參考文獻 (1)
引用資料與參考文獻
Abstract
Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty.
Authors:Tagalakis AD, Graham IR, Riddell DR, Dickson JG, Owen JS,
Journal:J Biol Chem
PubMed ID:11278248
'Apolipoprotein (apo) E is a polymorphic plasma protein, synthesized mainly by liver. Here, we evaluate whether synthetic DNA-RNA oligonucleotides (chimeraplasts) can convert a dysfunctional isoform, apoE2 (C --> T, R158C), which causes Type III hyperlipidemia and premature atherosclerosis, into apoE3. First, we treated recombinant Chinese hamster ovary cells stably secreting ... More